Literature DB >> 17362746

Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury.

P Semedo1, P M Wang, T H Andreucci, M A Cenedeze, V P A Teixeira, M A Reis, A Pacheco-Silva, N O S Câmara.   

Abstract

BACKGROUND: Ischemia and reperfusion injury (I/R) is the major cause of acute renal failure (ARF) with high mortality rates. Because alternative therapies are needed, we investigated the use of stem cell therapy to modulate inflammation in a renal I/R model.
METHODS: To study kidney I/R injury, we clamped bilateral pedicles for 60 minutes. Mesenchymal stem cells (MSC), which had been isolated and cultivated in plastic flasks, were administered to mice 6 hours after injury. Real-time polymerase chain reaction was used to quantify interleukin (IL)-4 and IL-1beta mRNAs. Proliferative nuclear cell antigen (PCNA) was used to calculate tubular regeneration.
RESULTS: Administration of MSC attenuated renal injury; serum creatinine and plasma urea levels were significantly reduced 24 hours after reperfusion. PCNA immunohistochemistry showed that regeneration occurred faster in renal tissues of animals that received MSC than in tissues of control animals. Analyses of cytokine expression in renal tissue demonstrated a greater level of anti-inflammatory cytokines in MSC-treated animals.
CONCLUSION: These results showed an antiinflammatory pattern in MSC-treated animals, demonstrating the potential of MSC to modulate I/R, leading to earlier regeneration of damaged renal tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362746     DOI: 10.1016/j.transproceed.2007.01.036

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  24 in total

Review 1.  The role of microvesicles in tissue repair.

Authors:  Ciro Tetta; Stefania Bruno; Valentina Fonsato; Maria Chiara Deregibus; Giovanni Camussi
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

2.  Molecular characterization and xenogenic application of Wharton's jelly derived caprine mesenchymal stem cells.

Authors:  M D Pratheesh; Nitin E Gade; Pawan K Dubey; Amar Nath; T B Sivanarayanan; D N Madhu; Bhaskar Sharma; G Saikumar; G Taru Sharma
Journal:  Vet Res Commun       Date:  2014-03-07       Impact factor: 2.459

3.  Combination stem cell therapy for heart failure.

Authors:  Thomas E Ichim; Fabio Solano; Fabian Lara; Jorge Paz Rodriguez; Octav Cristea; Boris Minev; Famela Ramos; Erik J Woods; Michael P Murphy; Doru T Alexandrescu; Amit N Patel; Neil H Riordan
Journal:  Int Arch Med       Date:  2010-04-14

4.  Immature Dental Pulp Stem Cells Showed Renotropic and Pericyte-Like Properties in Acute Renal Failure in Rats.

Authors:  Michele A Barros; João Flávio Panattoni Martins; Durvanei Augusto Maria; Crisitiane Valverde Wenceslau; Dener Madeiro De Souza; Alexandre Kerkis; Niels Olsen S Câmara; Julio Cesar C Balieiro; Irina Kerkis
Journal:  Cell Med       Date:  2014-03-24

5.  Novel regulations of MEF2-A, MEF2-D, and CACNA1S in the functional incompetence of adipose-derived mesenchymal stem cells by induced indoxyl sulfate in chronic kidney disease.

Authors:  Duyen Thi Do; Nam Nhut Phan; Chih-Yang Wang; Zhengda Sun; Yen-Chang Lin
Journal:  Cytotechnology       Date:  2016-08-22       Impact factor: 2.058

Review 6.  Kidney repair and stem cells: a complex and controversial process.

Authors:  Brian A Yeagy; Stephanie Cherqui
Journal:  Pediatr Nephrol       Date:  2011-02-19       Impact factor: 3.714

Review 7.  Acute kidney injury in the elderly population.

Authors:  Rahmi Yilmaz; Yunus Erdem
Journal:  Int Urol Nephrol       Date:  2009-08-26       Impact factor: 2.370

8.  Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.

Authors:  Krisztián Németh; Asada Leelahavanichkul; Peter S T Yuen; Balázs Mayer; Alissa Parmelee; Kent Doi; Pamela G Robey; Kantima Leelahavanichkul; Beverly H Koller; Jared M Brown; Xuzhen Hu; Ivett Jelinek; Robert A Star; Eva Mezey
Journal:  Nat Med       Date:  2008-11-21       Impact factor: 53.440

Review 9.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

10.  Activated omentum slows progression of CKD.

Authors:  Ignacio Garcia-Gomez; Nishit Pancholi; Jilpa Patel; Krishnamurthy P Gudehithlu; Periannan Sethupathi; Peter Hart; George Dunea; Jose A L Arruda; Ashok K Singh
Journal:  J Am Soc Nephrol       Date:  2014-03-13       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.